Used as a key intermediate in the synthesis of pharmaceuticals, particularly in the development of central nervous system (CNS) active agents. Its structure supports the creation of compounds with antidepressant, anxiolytic, and neuroprotective properties. The trifluoromethoxy group enhances metabolic stability and membrane permeability, making it valuable in drug design for improving bioavailability. Also employed in the preparation of selective enzyme inhibitors and receptor modulators in medicinal chemistry research.